Haemonetics Corp. | Cash Flow
Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
35,148.00
16,897.00
55,579.00
26,268.00
45,572.00
55,019
Depreciation, Depletion & Amortization
81,740.00
86,053.00
89,911.00
89,733.00
89,247.00
109,418
Other Funds
2,395.00
1,569.00
-
-
-
44,243
Funds from Operations
137,638.00
126,847.00
148,066.00
153,921.00
140,371.00
222,031
Changes in Working Capital
1,886.00
331.00
26,201.00
5,817.00
79,979.00
62,750
Net Operating Cash Flow
139,524.00
127,178.00
121,865.00
159,738.00
220,350.00
159,281
Capital Expenditures
73,648.00
122,220.00
102,405.00
76,135.00
74,799.00
Sale of Fixed Assets & Businesses
488.00
452.00
637.00
2,822.00
11,758.00
Purchase/Sale of Investments
23,124.00
-
-
-
-
Net Investing Cash Flow
105,830.00
121,768.00
104,768.00
73,313.00
63,041.00
Issuance/Reduction of Debt, Net
43,548.00
8,736.00
20,013.00
93,410.00
60,983.00
Net Financing Cash Flow
20,700.00
33,160.00
62,624.00
60,413.00
120,643.00
Net Change in Cash
13,349.00
31,807.00
45,539.00
24,441.00
40,605.00
Free Cash Flow
65,876.00
4,958.00
19,460.00
83,603.00
145,551.00
Deferred Taxes & Investment Tax Credit
202.00
4,230.00
1,038.00
6,800.00
5,828.00
13,351
Net Assets from Acquisitions
9,546.00
-
-
-
-
Change in Capital Stock
20,453.00
24,980.00
42,611.00
32,997.00
59,660.00
Exchange Rate Effect
355.00
4,057.00
12.00
1,571.00
3,939.00
Other Uses
-
-
3,000.00
-
-
About Haemonetics
View Profile
